Influenza- and respiratory syncytial virus-associated mortality and hospitalisations

European Respiratory Journal

Volumn 30, Issue 6, 2007, Pages 1158-1166

  Jansen, A G S C ^a   Sanders, E A M ^b   Hoes, A W ^a   Van Loon, A M ^a   Hak, E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Hospitalisations; Influenza viruses; Mortality; Respiratory syncytial viruses

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CHILD CARE; CONTROLLED STUDY; DISEASE SURVEILLANCE; ELDERLY CARE; EUROPE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS; MORTALITY; NEWBORN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT;

ADOLESCENT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NETHERLANDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SEASONS;

EID: 37749047303     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00034407     Document Type: Article

References (38)

1. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87: 1944-1950.
2. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186.
3. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333-1340.
4. Van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21: 1780-1785.
5. Advisory Committee on Immunization Practices, Smith NM, Bresee JS, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55: 1-42.
6. Groll DL, Thomson DJ. Incidence of influenza in Ontario following the Universal Influenza Immunization Campaign. Vaccine 2006; 24: 5245-5250.
7. Mullooly JP, Bridges CB, Thompson WW, et al. Influenza-and RSV-associated hospitalizations among adults. Vaccine 2007; 25: 846-855.
8. Centers for Disease Control and Prevention. Surveillance for laboratory-confirmed, influenza-associated hospitalizations - Colorado, 2004-05 influenza season. MMWR Morb Mortal Wkly Rep 2005; 54: 535-537.
9. Poehling KA, Edwards KM, Weinberg GA, et al. The under recognized burden of influenza in young children. N Engl J Med 2006; 355: 31-40.
10. Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 1999; 26: 189-195.
11. Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol 2006; 48: 1498-1502.
12. Madjid M, Awan I, Ali M, Frazier L, Casscells W. Influenza and atherosclerosis: vaccination for cardiovascular disease prevention. Expert Opin Biol Ther 2005; 5: 91-96.
13. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358: 1410-1406.
14. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179: 25-30.
15. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect 1996; 116: 51-63.
16. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. New Eng J Med 2005; 352: 1749-1759.
17. Venkatesh MP, Weisman LE. Prevention and treatment of respiratory syncytial virus infection in infants: an update. Expert Rev Vaccines 2006; 5: 261-268.
18. Van den Brandhof WE, Kroes ACM, Bosman A, Peeters MF, Heijnen MLA. [Reporting virological diagnostics in The Netherlands. Representativity of data from the weekly viral reports.] Infectieziekten Bulletin 2002; 13: 110-113.
19. Heijnen MLA, Bartelds AIM, de Jong JC, Rimmelzwaan GF, Wilbrink B. [Influenza and RS virus infections during the winter 2000/2001.] Infectieziekten Bulletin 2001; 12: 2.
20. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-239.
21. Tacken M, Verheij R, Mulder J, van den Hoogen H, Braspenning J. Monitoring griepvacinatecampagne 2004. [Monitoring influenza vaccination campaign 2004.] Landelijk Informatie Netwerk Huisartsenzorg, Utrecht, The Netherlands; 2004.
22. O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113: 585-593.
23. Schanzer DL, Langley JM, Tam TWS. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J 2006; 25: 795-800.
24. Grijalva CG, Craig AS, Dupont WD, et al. Estimating influenza hospitalizations among children. Emerg Infect Dis 2006; 12: 103-109.
25. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002; 185: 147-152.
26. Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005; 59: 586-590.
27. Wong CM, Yang L, Chan KP, et al. Influenza-associated hospitalization in a subtropical city. PLoS Med 2006; 3: e121.
28. Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004; 190: 1369-1373.
29. Heikkinen T. Influenza in children. Acta Paediatr 2006; 95: 778-784.
30. Smith S, Demicheli V, Di Pietrantonj C, et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2006; 1: CD004879.
31. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of infuenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-527.
32. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661-1665.
33. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Eng J Med 2003; 348: 1322-1332.
34. Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20: 1831-1836.
35. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24: 1159-1169.
36. Lee MS, Walker RE, Mendelman PM. Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials. Hum Vaccin 2005; 1: 6-11.
37. Rietveld E, Vergouwe Y, Steyerberg EW, Huysman MW, de Groot R, Moll HA. Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule. Pediatr Infect Dis J 2006; 25: 201-207.
38. Fleming DM, Elliot AJ, Cross KC. Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periods. Epidemiol Infect 2007; 12: 1-10.